BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation

BMP2 downregulates urokinase-type plasminogen activator via p38 MAPK: Implications in C2C12 cells myogenic differentiation

Bone morphogenetic protein (BMP)2 strongly impacts the differentiation program of myoblast cells by inhibiting myogenesis and inducing osteogenic differentiation. In flip, extracellular matrix (ECM) proteinases, equivalent to urokinase-type plasminogen activator (uPA), can affect the destiny of muscle stem cells by taking part in ECM reorganization. Though each BMP2 and uPA have antagonistic roles in muscular…

Read More

B-Galalactosidase Recombinant Aden

Background Recombinant adenoviruses have enormous potential in both research and therapeutic applications. There are numerous advantages in using adenovirus to introduce genetic material into host cells. The range of permissive host cells is very wide. The virus has been used to infect many types of mammalian cells (both replicative and non-replicative) for high expression of…

Read More